Faculty profile

Marianna Foldvari

ResearcherSchool of PharmacyUniversity of Waterloo

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a University of Waterloo directory, so their courses may be missing. Find their university profile.

Marianna Foldvari

Researcher

School of Pharmacy

Health Sciences

University of Waterloo

Waterloo, Ontario, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
7 publications in the last five years, latest in 2026.
Senior (last) author on 5 recent papers, a sign of leading a research group.
Principal investigator on 5 research grants (4 NSERC, 1 CIHR), most recently in 2020.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Drug Delivery Gene Targeting Gene Therapy Glaucoma In Vivo Testing Nanoparticles Neuroprotection Non-Invasive Delivery Systems

Latest papers

Nose-to-brain delivery of IRX4204 by cell-adhesion peptide-functionalized gemini surfactant-phospholipid nanoparticles.
RSC pharmaceutics · 2026 · senior author
In Vivo and Ex Vivo Evaluation of a Novel Method for Topical Delivery of Macromolecules Through the Stratum Corneum for Cosmetic Applications.
Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.] · 2025 · senior author
Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.
Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology · 2025 · senior author

All 46 publications

Latest funding

Scalable Liquid-Liquid Encapsulation for Drug Delivery
NSERC · 2022 · Co-investigator
$25,000
Nanoparticle-based gene editing delivery systems
NSERC · 2020 · Principal investigator
$275,000
Non-invasive drug delivery by phytospherix nanoparticles
NSERC · 2016 · Principal investigator
$25,000

All 9 grants and awards

46 publications.

Nose-to-brain delivery of IRX4204 by cell-adhesion peptide-functionalized gemini surfactant-phospholipid nanoparticles.

Hakim A, Kasheke GDS, Robertson GS, Foldvari M

RSC pharmaceutics2026Senior author

DOI: 10.1039/d6pm00414h PMID: 42719635

In Vivo and Ex Vivo Evaluation of a Novel Method for Topical Delivery of Macromolecules Through the Stratum Corneum for Cosmetic Applications.

Moradi A, Bhatia AC, Behr K, Napekoski K, Foldvari M

Dermatologic surgery : official publication for American Society for Dermatologic Surgery [et al.]2025Senior author

DOI: 10.1097/dss.0000000000004504 PMID: 39635989

Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.

Araujo Cirne C, Foldvari M

Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology2025Senior author

DOI: 10.1002/wnan.70000 PMID: 39800783

Preserving and enhancing mitochondrial function after stroke to protect and repair the neurovascular unit: novel opportunities for nanoparticle-based drug delivery.

Novorolsky RJ, Kasheke GDS, Hakim A, Foldvari M, Dorighello GG, Sekler I, Vuligonda V, Sanders ME, Renden RB, Wilson JJ, Robertson GS

Frontiers in cellular neuroscience2023

DOI: 10.3389/fncel.2023.1226630 PMID: 37484823

BDNF gene delivery to the retina by cell adhesion peptide-conjugated gemini nanoplexes in vivo.

Narsineni L, Chen DW, Foldvari M

Journal of controlled release : official journal of the Controlled Release Society2023Senior author

DOI: 10.1016/j.jconrel.2023.05.033 PMID: 37257566

Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems.

Hakim A, Guido B, Narsineni L, Chen DW, Foldvari M

Advanced drug delivery reviews2023Senior author

DOI: 10.1016/j.addr.2023.114781 PMID: 36940751

EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.

Huh H, Chen DW, Foldvari M, Slavcev R, Blay J

Frontiers in immunology2022

DOI: 10.3389/fimmu.2022.957233 PMID: 36591314

CpG-ODN induced antimicrobial immunity in neonatal chicks involves a substantial shift in serum metabolic profiles.

Goonewardene KB, Karu N, Ahmed KA, Popowich S, Chow-Lockerbie B, Ayalew LE, Karunarathna R, Gunawardana T, Liu M, Tikoo SK, Foldvari M, Willson P, Mandal R, Wishart DS, Gomis S

Scientific reports2021

DOI: 10.1038/s41598-021-88386-2 PMID: 33907214

Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.

Narsineni L, Foldvari M

Pharmaceutical research2020Senior author

DOI: 10.1007/s11095-020-02836-6 PMID: 32666411

Mucosal delivery of CpG-ODN mimicking bacterial DNA via the intrapulmonary route induces systemic antimicrobial immune responses in neonatal chicks.

Goonewardene K, Ahmed KA, Gunawardana T, Popowich S, Kurukulasuriya S, Karunarathna R, Gupta A, Ayalew LE, Lockerbie B, Foldvari M, Tikoo S, Willson P, Gomis S

Scientific reports2020

DOI: 10.1038/s41598-020-61683-y PMID: 32210244

Something wrong or missing on this profile? Suggest a correction

Marianna Foldvari

Research

Latest papers

Latest funding

Nose-to-brain delivery of IRX4204 by cell-adhesion peptide-functionalized gemini surfactant-phospholipid nanoparticles.

In Vivo and Ex Vivo Evaluation of a Novel Method for Topical Delivery of Macromolecules Through the Stratum Corneum for Cosmetic Applications.

Pulmonary Delivery of Nonviral Nucleic Acid-Based Vaccines With Spotlight on Gold Nanoparticles.

Preserving and enhancing mitochondrial function after stroke to protect and repair the neurovascular unit: novel opportunities for nanoparticle-based drug delivery.

BDNF gene delivery to the retina by cell adhesion peptide-conjugated gemini nanoplexes in vivo.

Gene therapy strategies for glaucoma from IOP reduction to retinal neuroprotection: Progress towards non-viral systems.

EGFR-targeted bacteriophage lambda penetrates model stromal and colorectal carcinoma tissues, is taken up into carcinoma cells, and interferes with 3-dimensional tumor formation.

CpG-ODN induced antimicrobial immunity in neonatal chicks involves a substantial shift in serum metabolic profiles.

Dicationic Amino Substituted Gemini Surfactants and their Nanoplexes: Improved Synthesis and Characterization of Transfection Efficiency and Corneal Penetration In Vitro.

Mucosal delivery of CpG-ODN mimicking bacterial DNA via the intrapulmonary route induces systemic antimicrobial immune responses in neonatal chicks.

Scalable Liquid-Liquid Encapsulation for Drug Delivery

Nanoparticle-based gene editing delivery systems

Non-invasive drug delivery by phytospherix nanoparticles

Rational design of soft nanoparticles for non-invasive drug delivery

Oligodeoxynucleotides containing CpG motifs (CpG-ODN) as an alternative to antibiotics in the broiler chicken industry

Targeted nanomedicines for gene therapy applications.

Formulation and delivery of immunostimulatory oligodeoxynucleotides containing CpG motifs (CpG-ODN) with carbon nanotubes (CNTs) against poultry diseases.

Micro- and nanoscale delivery systems for macromolecules: gene delivery

Self-assembling peptides for anticancer drug delivery

Frequent collaborators

Mohammad Kohandel